Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hybridon receives clearance to initiate further GEM-132 trials

April 8, 1997

Antibacterial mupirocin sulfamates from SmithKline Beecham

April 7, 1997

Novel antifungal discovered by Takara Shuzo

April 4, 1997

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

April 4, 1997

Phase I/II results of MedImmune's MEDI-493 reported

April 3, 1997

IVAX's generic acyclovir tentatively approved

April 3, 1997

Stromectol available in U.S. for parasitic infections

April 3, 1997

Uriach discloses new antifungal agents

April 3, 1997

IntraBiotics/Synt:em to develop protegrin analogues

April 2, 1997

FDA tentatively approves generic acyclovir

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...